Steven Kelly

Insider Reports History

Entity
Individual
Location
C/O Innovive Pharmaceuticals, Inc., 555 Madison Avenue, 25 Th Floor, New York, NY
Signature
/s/ Richard Morris, as Attorney-in-Fact for Steven Kelly
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Kelly:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Carisma Therapeutics Inc. President and CEO, Director Stock Option (Right to Buy) 125K Jun 17, 2024 Direct
ARTELO BIOSCIENCES, INC. Director Stock Option (right to buy) 1.08K Feb 28, 2024 Direct

Insider Reports Filed by Steven Kelly

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CARM Carisma Therapeutics Inc. Jun 17, 2024 1 $0 4 Jun 18, 2024 President and CEO, Director
ARTL ARTELO BIOSCIENCES, INC. Feb 28, 2024 12 $0 4 Mar 1, 2024 Director
CARM Carisma Therapeutics Inc. Jan 31, 2024 1 $0 4 Feb 2, 2024 President and CEO, Director
ARTL ARTELO BIOSCIENCES, INC. Aug 4, 2023 1 $0 4 Aug 8, 2023 Director
ARTL ARTELO BIOSCIENCES, INC. Jun 30, 2023 1 $0 4 Jul 3, 2023 Director
CARM Carisma Therapeutics Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 President and CEO, Director
CARM Carisma Therapeutics Inc. Mar 7, 2023 2 $0 4 Mar 9, 2023 President and CEO, Director
CARM Carisma Therapeutics Inc. Mar 7, 2023 0 $0 3 Mar 9, 2023 President and CEO, Director
ARTL ARTELO BIOSCIENCES, INC. Jun 24, 2022 1 $0 4 Jun 27, 2022 Director
ARTL ARTELO BIOSCIENCES, INC. Jul 16, 2021 1 $0 4 Jul 26, 2021 Director